#POLB Poolbeg Pharma PLC - Appointment to SAB
- Has appointed Adrian Kilcoyne to its Scientific Advisory Board.
- He brings 20+ years of expertise in oncology and immunology drug development and is currently Chief Medical Officer at Cellectis SA.
shorturl.at/JUqIq
Novus Comms January 2026 #newsletter covering
✅ Research Talks Jan 11th, 18th & 25th @stockbox.bsky.social covering #ECR #FDR #KDNC #CMR #COD #GRX #EV1 #HREE #SVML #DGQ #EGT #WWI. RNS covering #ELEG #HVO & #POLB. Interview with @cadenceminerals.bsky.social #KDNC
Read: mailchi.mp/branduk/novu...
#POLB Poolbeg Pharma PLC - POLB 001 LPS Challenge Trial Paper Published
- POLB 001 reduced key inflammatory biomarkers & immune cell recruitment following LPS challenge in healthy volunteers
- POLB 001 was safe and well tolerated across all dose levels
novuscomms.com/2026/01/28/p...
#POLB Poolbeg Pharma - Letter to Shareholders –2025 a year of progress
- Publishes an end of year letter from the Company's Executive Chair, Cathal Friel, providing an overview of the significant progress made by the Company in 2025 and outlook for 2026.
novuscomms.com/2025/12/18/p...
Ultimate Breakout #podcast I discuss:
✅ Poolbeg Pharma #POLB
✅ Ajax Resources #AJAX
✅ Anglesey Mining #AYM
with Justin Pitchford looking at the charts #technicalanalysis #TA
#immunotherapy #pharma #gold #copper #silver #Mining #MiningNews #Exploration #Resources #Investing
youtu.be/3FOYfoIACUo
#POLB Poolbeg Pharma PLC - POLB 001 to feature in CRS research programme
- POLB 001 topical trial will feature in a CRS research programme and lead alongside Johnson & Johnson and other partners, supported by a £3.4m MRC Prosperity Partnership grant.
novuscomms.com/2025/12/08/p...
Novus Comms November 2025 #newsletter
✅ Research Talks Nov 2nd, 9th & 16th StockBox Media covering #CINH #MANO #80M #ZOO #KDNC #PALM #TRI #AAI #URU #CMR #OHGR #MPAL. Ultimate Breakout podcasts Nov 30 covering #URU #KDNC #MDH #SBDS + RNS #HVO #POLB #ELEG
read: mailchi.mp/branduk/novu...
#POLB Poolbeg Pharma PLC - POLB 001 European Patent granted
- Granted Poolbeg's European Immunomodulator II patent application covering POLB 001 for the treatment of severe influenza.
novuscomms.com/2025/11/20/p...
Poolbeg is entering a catalyst-rich phase. POLB-001 is in Phase 2a with 2026 data due, while its oral GLP-1 obesity drug offers a second major shot. With £10m cash and funding into 2027, Poolbeg could be well-positioned for growth.
#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Poolbeg’s planned merger with Hookipa collapsed in early 2025, sending shares lower. The company rebounded with funding, partnerships, and a Phase 2a trial launch, showing resilience in a volatile small-cap sector.
#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Poolbeg expanded POLB-001 patent coverage to South Korea in 2025, adding to rights in the U.S., Europe, and China. Combined with Orphan Drug status, Poolbeg now has strong IP protection in key global markets.
#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Poolbeg’s obesity programme develops an oral GLP-1 drug to rival injectables like Wegovy and Ozempic. With trials planned for late 2025, it could offer a compliance-friendly alternative in a booming global market.
#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Poolbeg’s POLB-001 addresses risks from bispecific antibody therapies. It could become the first preventative CRS treatment, with FDA Orphan Drug exclusivity adding commercial strength in oncology markets.
#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Poolbeg’s POLB-001 targets the p38 MAP kinase pathway to control cytokines like IL-6 and TNF-alpha, aiming to prevent immune storms while preserving cancer therapy outcomes. If proven, it could unlock safer immunotherapy use.
#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Poolbeg, valued at £26m, is a micro-cap targeting billion-dollar markets in oncology and obesity. Investors view it as high-risk, high-reward, with potential for re-rating on clinical success.
#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Poolbeg’s Executive Chair Cathal Friel bought 4m shares at 3p in June 2025, while CEO Jeremy Skillington also holds stock. Former Glen Dimplex CEO Sean O’Driscoll added credibility with a 5.7% stake.
#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Poolbeg raised £4.7m in June 2025, boosting cash to ~£10m. The company is funded into 2027, giving runway to deliver trial results. Partnerships further cut costs, making Poolbeg one of AIM’s stronger biotechs financially.
#POLB #Biotech #Investing #SmallCaps #AIMStocks #StocksToWatch #Pharma
Poolbeg’s POLB-001 was granted FDA Orphan Drug Designation in May 2025 for cytokine release syndrome, providing regulatory incentives and exclusivity potential. A Phase 2a trial is underway with results expected in 2026.
#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
Poolbeg is preparing to launch Phase 2A trial of POLB-001 for cytokine release syndrome. ACT has been appointed to run the study, with The Christie NHS Trust and other UK centres selected. First-patient dosing is pending, with interim data expected summer 2026.
#POLB #Biotech #Investing #SmallCaps
Poolbeg Pharma is a London-listed biotech (£26m cap) developing POLB-001 for oncology support care and an oral GLP-1 obesity drug. Using a lean model, it advances drugs to proof-of-concept before out-licensing.
#POLB #Biotech #Pharma #Investing #SmallCaps #Stockstowatch #Stocks
#POLB Poolbeg Pharma plc - Interim Results for the six months to 30 June 2025
- Cash balance of £10.0 million as at 30 June 2025
- incl £4.865 million gross proceeds raised as part of an oversubscribed and upsized fundraise
novuscomms.com/2025/09/29/p...
#POLB Poolbeg Pharma PLC - POLB 001 Phase 2a Trial Update
- Signed an agreement for a specialist blood cancer trials organisation, Accelerating Clinical Trials LTD ("ACT")
- Along with supply of an approved bispecific antibody drug for the trial.
shorturl.at/3LP6E
"It's Time for the Port of Long Beach to Pivot AWAY from Offshore Wind Energy" I break down why the Pier Wind project is at risk and why Calif must pivot to other energy sources.
Listen here: youtu.be/HtROSWRIbOE?...
#LongBeach #California #CleanEnergy #EnergyPolicy #POLB #RenewableEnergy 🌍 🍃 🌊
Quoted Micro 2 June 2025 - #ADB #AGL #APTA #AVG #AXL #BMS #C4XD #CFCP #COIN #COOK #FDEV #FILE #HEV #HRIP #HVO #IES #IGR #INSE #INT #KNDR #KR1 #LDG #LFT #MARU #MET #PBX #POLB #REAT #S247 #SCSP #SVEN #SWC #TAP #TOO #VLRM #WAD #ZNT
www.branduk.net/quoted-micro...
Brand Comms Highlights #Newsletter May 2025:
✅ #FCM #KDNC #HREE #MDH #BRES #AYM #ECR #VVV #GRX #URU #SVML #SCSP #4DM
✅ StockBox Research Talks May 5th, 12th, 18th & 25th #GSCU #BBSN #ECR #W7L #MOG #BRES #DKL #EGT #GROC #BGD #KING #MDH #URU #COIN #SWC & #POLB
Read: mailchi.mp/branduk/bran...
Novus Comms May 2025 #newsletter covering
StockBox Media Research Talks May 5th | May 12th | May 18th & May 25th covering #GSCU #BBSN #ECR #W7L #MOG #BRES #DKL #EGT #GROC #BGD #KING #MDH #URU #COIN #SWC & #POLB
Plus announcements from #EGT #POLB #TSP #HVO
read: mailchi.mp/branduk/novu...
Quoted Micro 26 May 2025 - #AAI #AJAX #ARBB #ART #AST #BMK #CER #CGNI #CLX #COIN #GCON #GDH #GGP #INC #INSE #KASH #LUCE #MDH #NBB #NYR #PMGL #POLB #QUOTED #MICRO #REVB #RNO #SNOX #SSP #SWC #THRV #TLY #TMR #TSP #TTA #VEL #VLRM #WAFR #WCAP #WTG #XSG #ZTF
#stocks
www.branduk.net/quoted-micro...
🏳️🌈 #POLB is proud to support the annual Pride Parade and Festival in Long Beach as part of its sponsorship program!
The sponsorship program is open now for the May call! Apply online by May 30. ow.ly/KMHr50VVieN
Today's StockBox Media #podcast, @alangreenstocks.bsky.social & Daniel Flynn discuss:
✅ URU Metals #URU
✅ @coinsilium.bsky.social #COIN
✅ @smartweb.bsky.social UK #SWC
✅ Poolbeg Pharma #POLB
with Mark Fairbairn
#nickel #zebediela #SouthAfrica #mining #bitcoin #Investing
youtu.be/yDb7ht0yTtc
Reflections on the Port Building. Long Beach, California.
#photography #fujifilm #reflection #glass #tower #buildings #POLB #LongBeach
